These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 909105)
1. Environmental factors in glial tumor response to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea: effect of cell confluence. Maker HS; Syed HH; Lehrer GM J Natl Cancer Inst; 1977 Nov; 59(5):1427-9. PubMed ID: 909105 [No Abstract] [Full Text] [Related]
2. DNA damage in the intracerebral rat gliosarcoma 9L treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Gutin PH; Hilton J; Fein VJ; Allan AE; Rottman A; Walker MD Cancer Res; 1977 Oct; 37(10):3761-5. PubMed ID: 908019 [No Abstract] [Full Text] [Related]
3. Formulation and biological distribution of radiolabeled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in an animal tumor model. Castronovo FP; Potsaid MS; Kopiwoda S Cancer Res; 1980 Oct; 40(10):3473-4. PubMed ID: 7438035 [TBL] [Abstract][Full Text] [Related]
4. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950 [TBL] [Abstract][Full Text] [Related]
5. Comparison of biochemical and biological effects of four nitrosoureas with differing carbamoylating activities. Kann HE Cancer Res; 1978 Aug; 38(8):2363-6. PubMed ID: 149589 [TBL] [Abstract][Full Text] [Related]
6. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. Ewig RA; Kohn KW Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823 [No Abstract] [Full Text] [Related]
7. Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins. Woolley PV; Dion RL; Kohn KW; Bono VH Cancer Res; 1976 Apr; 36(4):1470-4. PubMed ID: 4221 [TBL] [Abstract][Full Text] [Related]
8. Effect of phospholipids on maintenance of the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous suspension. Maker HS; Syed HH; Lehrer GM J Natl Cancer Inst; 1978 May; 60(5):1055-7. PubMed ID: 642027 [TBL] [Abstract][Full Text] [Related]
9. Quantitative dose-response relations for the cytotoxic activity of chloroethylnitrosoureas in cell culture. Weinkam RJ; Deen DF Cancer Res; 1982 Mar; 42(3):1008-14. PubMed ID: 7059967 [TBL] [Abstract][Full Text] [Related]
10. Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives. Drewinko B; Barlogie B; Freireich EJ Cancer Res; 1979 Jul; 39(7 Pt 1):2630-6. PubMed ID: 445465 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma. Laurent G; Atassi G; Hildebrand J Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049 [TBL] [Abstract][Full Text] [Related]
12. Brain tumor chemotherapy using a rat glioma model. Tamura M; Mennel HD; Zülch KJ J Cancer Res Clin Oncol; 1979 May; 94(1):39-46. PubMed ID: 468898 [TBL] [Abstract][Full Text] [Related]
13. Review of mechanism of action studies of the nitrosoureas. Bono VH Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364 [No Abstract] [Full Text] [Related]
14. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU). Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438 [TBL] [Abstract][Full Text] [Related]
15. Effects of nitrosoureas on human DNA polymerase activities from acute and chronic granulocytic leukemia cells. Chuang RY; Laszlo J; Keller P Biochim Biophys Acta; 1976 Apr; 425(4):463-8. PubMed ID: 1063042 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro. Begleiter A; Lam HP; Goldenberg GJ Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367 [TBL] [Abstract][Full Text] [Related]
17. The effect of a novel taurine nitrosourea, 1-(2-chloroethyl)-3-[2-(dimethylaminosulfonyl)ethyl]-1-nitrosour ea (TCNU) on cytotoxicity, DNA crosslinking and glutathione reductase in lung carcinoma cell lines. Tew KD; Dean SW; Gibson NW Cancer Chemother Pharmacol; 1987; 19(4):291-5. PubMed ID: 2954712 [TBL] [Abstract][Full Text] [Related]
18. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU. Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells. Drewinko B; Loo TL; Gottlieb JA Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749 [TBL] [Abstract][Full Text] [Related]
20. Inhibition and recovery of DNA synthesis in host tissues and sensitive and resistant B16 melanoma after 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea, a predictor of therapeutic efficacy. Brereton HD; Bryant TL; Young RC Cancer Res; 1975 Sep; 35(9):2420-5. PubMed ID: 1149044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]